TrueBlue (TBI) PT Lowered to $24 at BMO Capital
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $9.63 +2.01%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
BMO Capital analyst Jeffrey Silber lowered the price target on TrueBlue (NYSE: TBI) to $24.00 (from $26.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Procore Technologies, Inc (PCOR) PT Lowered to $56 at DA Davidson Amid 'Less Favorable' Construction Dynamics
- Eli Lilly (LLY) PT Raised to $1,500 at JPMorgan as Guidance Raise Expected
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
